BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2000
View Archived Issues
Bioenvision to codevelop clofarabine for leukemia; mode of action examined at UCSD
Read More
Proteomics collaboration between Myriad Genetics and Bayer extended and expanded
Read More
Orphan grants Kirin Brewery marketing and distribution rights to Busulfex for Asia
Read More
Pharmaccine collaboration between Oxxon Pharmaccines and Ludwig Institute
Read More
Competitive metabotropic glutamate receptor antagonist with some selectivity for mglu5 subtype
Read More
ArQule and Acadia join forces in GPCR-targeted drug discovery
Read More
OSI Pharmaceuticals reviews progress during the year
Read More
Cubist completes enrollment in phase III skin & soft tissue infection trial
Read More
Highly selective tracer for mapping brain A2A receptors discovered by Kyowa Hakko
Read More
Merck KGaA establishes Merck Pharma in Italy through acquisition
Read More
Applied Molecular Evolution and Biosynexus to optimize antibacterial agent
Read More
Combination tgDCC-E1A/radiation therapy enters phase II
Read More
Meiji Milk and Takeda to codevelop MT-201 for treatment of cryptomeria pollinosis
Read More
Lilly and Sankyo to collaborate on CS-747 development
Read More
Advanced Magnetics submits sNDA for Feridex I.V. contrast agent
Read More
FDA approves Botox for cervical dystonia
Read More
R.W. Johnson seeks FDA approval for transdermal contraceptive
Read More
Celgene's NDA for d-MPH accepted for review by FDA
Read More
GlaxoSmithKline now listed on London and N.Y. stock exchanges
Read More
Otsuka reveals thiazole derivatives with potential broad therapeutic application
Read More
Takeda discloses compounds with potent adenosine A3 receptor-antagonist activity
Read More
Japan Science and Technology Corporation's unique compounds for diabetes and hypertension therapy
Read More
N-Aryl-alkylamides for CNS disorders claimed by Warner-Lambert
Read More
Arylamidines and cyclic amidines with broad clinical application reported by Merck & Co.
Read More